Election 2014
SENSEX NIFTY
YOU ARE HERE > MONEYCONTROL > MARKETS > PHARMACEUTICALS > News - Ranbaxy Laboratories
Ranbaxy Laboratories
BSE: 500359|NSE: RANBAXY|ISIN: INE015A01028|SECTOR: Pharmaceuticals
SET ALERT
|
ADD TO PORTFOLIO
|
WATCHLIST
LIVE
BSE
Apr 17, 13:30
468.55
2.4 (0.51%)
VOLUME 130,927
LIVE
NSE
Apr 17, 12:17
466.75
0.65 (0.14%)
VOLUME 543,925
Management Interviews on Ranbaxy Laboratories
Select Year: 2013 |  2012 |  2011 | 2010 | 2009 | 2008 | 2007 | 2000-2006
No ground for insider trading charges against Sun: Shanghvi 

5.17 pm | 09 Apr 2014 |  Source: CNBC-TV18

Dilip Shanghvi believes post the deal, Sun Pharma will keep the Ranbaxy brand alive and will work towards boosting the company's margins, significantl...

CCI nod for Sun-Ranbaxy deal likely in 6 months: KK Sharma 

2.37 pm | 09 Apr 2014 |  Source: CNBC-TV18

On Holcim – Lafarge, Sharma says India will be one of the markets where the companies' "scheme of divestiture will be needed"....

Sun chairman Makov confident of turning around Ranbaxy 

11.57 am | 09 Apr 2014 |  Source: CNBC-TV18

The 75-year-old Israel Makov, the former chief of Teva Pharma, is a respected figure in international corporate circles and his experience would come ...

Ranbaxy is good, cheap buy by Sun Pharma: Kewal Handa 

4.02 pm | 07 Apr 2014 |  Source: CNBC-TV18

Handa, who currently serves as chairman of Medybiz Pharma, said that this deal will be a big positive for Ranbaxy shareholders...

Sun may review Ranbaxy's portfolio: Pharmasianews 

2.24 pm | 07 Apr 2014 |  Source: CNBC-TV18

Vikas Dandekar thinks that Sun may review and trim Ranbaxy’s portfolio to avoid duplication....

Ranbaxy buyout to fortify presence in many mkts: Sun Pharma 

11.39 am | 07 Apr 2014 |  Source: CNBC-TV18

The deal will not only make Sun Pharma India’s largest pharma company but also, the largest Indian pharma company in the US....

Sun competent to handle Ranbaxy's FDA issues: Ajay Piramal 

9.13 am | 07 Apr 2014 |  Source: CNBC-TV18

According to Ajay Piramal, Chairman of Piramal Group, Daiichi couldn't handle FDA issues faced by Ranbaxy but Sun is competent to handle these issues....

Daiichi was unable to run Ranbaxy's generic biz: Malvinder 

8.29 am | 07 Apr 2014 |  Source: CNBC-TV18

Former Ranbaxy chairman and CEO Malvinder Singh blamed Daiichi Sankyo for what he claimed to be the Japanese drug major’s failure to build on the In...

SC notice to Ranbaxy over adulterated drug; stock sinks 5%

12.27 pm | 14 Mar 2014 |  Source: Moneycontrol.com

If a ban is imposed on the cholestoral drug, then Ranbaxy is likely to lose Rs 76 crore in revenues. ...

1
Quick Links for Ranbaxy Laboratories
Explore Moneycontrol
Stocks     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | Others
Mutual Funds     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.